Gold bars & granules © Heinz-Peter Bader/Reuters
Americans prefer gold, real estate

As the market wades through what many people hope is a sixth bull year, some have grown nervous about how long the run can go.

VIDEO ON MSN MONEY

Despite concerning news out of the eurozone, the pharmacy stock has been going strong.

By Jim J. Jubak Nov 11, 2011 7:32PM
Remember back on Oct. 27, when stocks looked like they might rally through the end of the year? I asked then whether it was time to go with the momentum or move to the sidelines and wait for a pullback.

Just two weeks later, the question seems downright silly. Not only have we had that pullback, but it’s hard to find any momentum in this market at all. (Or at least any momentum to the upside.)
 

A proper breakout could be on its way as early as next week. Watch for any pullback as a buying opportunity in these specific sectors.

By MoneyShow.com Nov 11, 2011 7:22PM
By Tom Aspray, MoneyShow.com

Stocks were choppy again last week, as Euro debt concerns once again pulled the rug out from under the market early Wednesday. Though the damage to the major averages was severe -- pretty much all stocks were down -- individual issues and most of the key exchange-traded funds held at first support.


The higher weekly close indicates that the bulls are still in charge, and the market leading behavior of the A/D lines (see below) that track the market’s internal health suggest prices could melt up next week.

 

The energy company had a great third quarter boosted by new development projects and key deals.

By Zacks.com Nov 11, 2011 7:19PM
By: Zacks Equity Research

We are upgrading our recommendation on Enterprise Products Partners (EPD) to outperform from neutral following a sterling third quarter, a pipeline of development projects and lucrative collaborations.

The results of the recently concluded quarter were backed by greater volumes of natural gas, natural gas liquids (NGLs) and crude oil along with a strong demand for NGLs in the U.S. petrochemical industry and global markets. 
Tags: EPDoil

The fast-food chain says it plans to publish the 200-page manuscript on the Internet next year.

By Kim Peterson Nov 11, 2011 7:11PM
We're about to learn a little more about Colonel Harland Sanders, the man behind the KFC fast-food chain, more than three decades after his death.

A KFC employee, rummaging around the company's archives, has uncovered a secret manuscript written by Sanders that promises to offer "real old-time American country and farm cooking before it's forgotten." 
Tags: YUM

Starbucks is moving into the premium-juice business with its acquisition of Evolution Fresh.

By Benzinga Nov 11, 2011 6:49PM

By John Thorpe, Benzinga Staff Writer


Nearly every day of my adult life, I have seen one or more people carrying around a cup of brand-name coffee. Nearly every time, I almost choked to death on my own laughter.


Now, those same folks will have the opportunity to entertain the frugal half of America by purchasing overpriced juice to go along with their overpriced coffee.

 

The disaster has hit the technology industry even before it could fully recuperate from the catastrophic March earthquake in Japan.

By Zacks.com Nov 11, 2011 6:40PM
 By: Zacks Equity Research
 
Nature seems to be wreaking vengeance on technology this year. The floods in Thailand have hit the sector hard, even before it could fully recuperate from the catastrophic earthquake in Japan in March. A supply breakdown is now feared to show up again. 

The case of the missing 4s has been solved.

By Motley Fool Pick of the Day Nov 11, 2011 4:25PM

By Selena Maranjian

 

Something strange happened last month, when Apple (AAPL) reported its quarterly earnings: They fell short of Wall Street's expectations. That has rarely happened in recent years, and the stock sank on the news, down about 7% initially. The episode was a good reminder that many companies have set us up to expect them to beat expectations -- and that bad things can happen when they don't.

 

The technology realm includes many frequent exceeders. For example:

 

Betting against the stock was finally allowed to begin this week, and traders have jumped in with enthusiasm.

By Kim Peterson Nov 11, 2011 3:15PM
Groupon (GRPN) has quickly become a favorite of short-sellers.

There is strong demand to borrow the stock and bet against it, Bloomberg reports. Shorts like to sell borrowed stock, expecting to profit by buying the shares back when the price drops. 
Tags: GRPN

Barnes & Noble will be one of the sector's top performers, one analyst says.

By TheStreet Staff Nov 11, 2011 3:00PM

By Jeannine Poggi, TheStreetTheStreet

 

Barnes & Noble (BKS) could double its stock price by 2013, according to an analyst.

 

"We believe as the market understands and appreciates the digital opportunity for the company and the sustainability of EBITDA at the store level, at least in the next few years the stock will prove to be one of the top performing retail/tech names in the market," Janney Capital Markets analyst David Strasser wrote in a note.

 

Numerologists say Nov. 11 is a lucky day. If that's the case, these 11 companies just might do the trick for investors.

By TheStreet Staff Nov 11, 2011 1:30PM

By Frank Byrt, TheStreetTheStreet

 

Numerologists say Friday is a lucky day, given the "11/11/11" date. Superstitious investors who have come to believe that traditional fundamental analysis methods are haywire in the seesawing marketplace may want to consider promising stocks with beaten-down prices of under $11.

 

Small-cap stocks, which typically include those trading for less than $11, are down 5.2% this year, compared with the large-cap bellwether S&P 500 ($INX) 0.6% decline. But the small-cappers show signs of having bottomed, as they are up 9.7% in the past month and 5.4% over 13 weeks, according to Morningstar.

 

These stocks show favorable chart patterns and are close to staging upside breakouts.

By MoneyShow.com Nov 11, 2011 1:25PM

Image: Oil drums (© Kevin Phillips/Digital Vision/age fotostock)By Tom Aspray, MoneyShow.com


Stocks have had a fairly choppy week, which makes the weekly close more important. A higher weekly close will be a positive sign, and the very strong action in crude oil on Thursday is a bullish signal for stocks.


As discussed previously, crude oil futures often break up or down ahead of the stock market. Wednesday's heavy selling in stocks increased the possibility of a deeper stock market correction, and while crude oil was also lower, it made new rally highs on Thursday.

 

With the introduction of its lightest roast ever in January, the company is attempting to reach a broader range of coffee drinkers.

By Trefis Nov 11, 2011 1:17PM
Image: Coffee (© Foodcollection RF/Getty Images/Getty Images)Starbucks (SBUX) is launching a lighter roast in January to attract customers who prefer milder coffee.

Based on its consumer research, Starbucks is offering its Blonde line for the estimated 40% of American coffee drinkers, or 54 million people, who prefer a lighter roast. The new coffees in the Blonde category include several under the Veranda and Willow blend names.

Starbucks' competitors in the specialty-coffee market include McDonald's (MCD), Caribou Coffee (CBOU) and Peet's Coffee (PEET). 

The advancement of tablets and smartphones has made Internet and mobile sales a prime strategy for many companies.

By Trefis Nov 11, 2011 1:02PM
The technology world is rapidly changing how business is done in the apparel industry. Suddenly, the advancement of tablets and smartphones has catapulted Internet and mobile sales as the prime strategy of retailers.

The teen apparel sector, including companies like Aeropostale (ARO), Abercombie & Fitch (ANF), American Eagle Outfitters (AEO) and Gap (GPS), is abuzz with these technical advancements in retail, with the 15-25 age group at the core of key smartphone and tablet users. 
Tags: AEOANFGPS

This biotechnology stock has the brightest growth prospects in Standard &Poor's large-cap biotech universe.

By TheStockAdvisors Nov 11, 2011 12:45PM

By Steven Silver, Standard & Poor's The Outlook

S&P Capital IQ considers Celgene (CELG) one of the biotechnology stocks best positioned for long-term growth, with solid core product growth, an advancing new product pipeline, and a strong financial position.

We expect Celgene to deliver earnings growth at a compound annual rate of 21% from 2010 through 2013, driven by expanding sales of its key cancer drug Revlimid. This figure represents the brightest growth prospects we see in the large-cap biotech industry.

We also believe that the positive resolution to a European review of the drug’s safety will further improve investor sentiment on the shares.

Celgene develops and markets pharmaceuticals to treat cancer, immunological, and inflammatory disorders.

 
Tags: CELG

The movement is facing winter, an increasingly crowded news environment and an inability to directly affect the high-paid CEOs and bankers it's targeting.

By MSN Money Partner Nov 11, 2011 12:14PM

By Peter Leeds, guest columnist

 

The faster anything rises, generally the faster it falls. Occupy Wall Street may be another example of this, as media coverage, social media activity, and activist numbers have all started dropping off. This is only expected to continue, especially with the onset of winter.


According to Google Trends, searches for Occupy Wall Street have fallen by 66% from their October 15th peak to November 11th. This is reinforced further by the Pew Research Center's weekly news index, which shows "Occupy Wall Street" dropping from 10% of total news coverage across their network on October 1st, to where it sits currently at less than 4%. 

 

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

108
108 rated 1
257
257 rated 2
439
439 rated 3
626
626 rated 4
499
499 rated 5
530
530 rated 6
713
713 rated 7
522
522 rated 8
339
339 rated 9
136
136 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
UPLULTRA PETROLEUM Corp10
EOGEOG RESOURCES Inc10
SWNSOUTHWESTERN ENERGY COMPANY10
TAT&T Inc9
COPCONOCOPHILLIPS9
More

Trending NOW

What’s this?

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market finished the Wednesday session on a modestly lower note, but it is worth mentioning today's retreat took place after six consecutive gains. The Dow Jones Industrial Average (-0.1%) and S&P 500 (-0.2%) settled not far below their flat lines, while the Nasdaq Composite (-0.8%) lagged throughout the session.

Equity indices started the day in the red, with the Nasdaq showing early weakness as large cap tech names and biotechnology weighed. The technology ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.